What is the ROCE (Return on Capital Employed) of Mabpharm this year?
The ROCE of Mabpharm is -0.97 undefined this year.
Mabpharm ROCE 2024
Mabpharm ROCE
-0.97
Ticker
2181.HK
ISIN
KYG5780F1046
In 2024, Mabpharm's return on capital employed (ROCE) was -0.97, a 94.14% increase from the -0.5 ROCE in the previous year.
Mabpharm Aktienanalyse
What does Mabpharm do?
Mabpharm Ltd is a biopharmaceutical company based in Suzhou, China. The company was founded in 2009 and specializes in the development and production of monoclonal antibodies. The business model of Mabpharm is to develop, produce, and sell high-quality biological drugs worldwide. The company works closely with customers to understand their needs and provide customized solutions. Mabpharm is divided into different divisions, each specialized in producing specific products. The main ones are oncology, immunology, cardiology, and infectious diseases. Each division offers a portfolio of products tailored to the needs of patients. In the field of oncology, Mabpharm offers a range of monoclonal antibodies that can be used to treat cancer. This includes therapies for breast cancer, gastric cancer, colorectal cancer, and lung cancer. The products have all been developed in collaboration with renowned partners worldwide and undergo rigorous clinical testing before being brought to market. Mabpharm's immunology division focuses on developing drugs for the treatment of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis. The products in this division have been specifically designed to regulate the immune system and suppress inflammation symptoms. The cardiology division of Mabpharm is dedicated to the development of drugs for the prevention and treatment of cardiovascular diseases. The products include antibodies for the treatment of lipid metabolism disorders and blood clots. Mabpharm's cardiovascular products also include a cholesterol-lowering medication that helps prevent heart attacks and strokes. In the infectious diseases division, Mabpharm has developed products for the treatment of hepatitis B and hepatitis C. These can reduce viral load and improve liver function. Furthermore, Mabpharm is also involved in the development of vaccines against COVID-19. Mabpharm has become a leading provider of monoclonal antibodies and biological drugs in China and internationally. The company works closely with academics and researchers to find innovative solutions and stay up to date with the latest scientific advancements. In conclusion, Mabpharm is an innovative company specializing in the research and development of biological drugs of all kinds. The company has a wide range of products that have been developed to meet the needs of patients worldwide. Mabpharm has emerged as a key player in the global market for biological drugs in recent years and is a company to watch when it comes to the future of biotechnology. Mabpharm ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROCE Details
Unraveling Mabpharm's Return on Capital Employed (ROCE)
Mabpharm's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.
Year-to-Year Comparison
Analyzing Mabpharm's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.
Impact on Investments
Mabpharm's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.
Interpreting ROCE Fluctuations
Changes in Mabpharm’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.
Frequently Asked Questions about Mabpharm stock
How has the ROCE (Return on Capital Employed) of Mabpharm developed compared to the previous year?
The ROCE of Mabpharm has increased by 94.14% increased compared to the previous year.
What does a high ROCE (Return on Capital Employed) mean for investors of Mabpharm?
A high Return on Capital Employed (ROCE) indicates that Mabpharm has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.
What does a low ROCE (Return on Capital Employed) mean for investors of Mabpharm?
A low ROCE (Return on Capital Employed) can indicate that Mabpharm has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.
How does an increase in ROCE from Mabpharm impact the company?
An increase in the ROCE of Mabpharm can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.
How does a reduction in the ROCE of Mabpharm affect the company?
A decrease in ROCE of Mabpharm can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.
What are some factors that can influence the ROCE of Mabpharm?
Some factors that can affect Mabpharm's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.
Why is the ROCE of Mabpharm so important for investors?
The ROCE of Mabpharm is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.
What strategic measures can Mabpharm take to improve the ROCE?
To improve the ROCE, Mabpharm can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.
How much dividend does Mabpharm pay?
Over the past 12 months, Mabpharm paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Mabpharm is expected to pay a dividend of 0 CNY.
What is the dividend yield of Mabpharm?
The current dividend yield of Mabpharm is .
When does Mabpharm pay dividends?
Mabpharm pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Mabpharm?
Mabpharm paid dividends every year for the past 0 years.
What is the dividend of Mabpharm?
For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.
In which sector is Mabpharm located?
Mabpharm is assigned to the 'Health' sector.
Wann musste ich die Aktien von Mabpharm kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Mabpharm from 10/15/2024 amounting to 0 CNY, you needed to have the stock in your portfolio before the ex-date on 10/15/2024.
When did Mabpharm pay the last dividend?
The last dividend was paid out on 10/15/2024.
What was the dividend of Mabpharm in the year 2023?
In the year 2023, Mabpharm distributed 0 CNY as dividends.
In which currency does Mabpharm pay out the dividend?
The dividends of Mabpharm are distributed in CNY.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Mabpharm
Our stock analysis for Mabpharm Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Mabpharm Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
